Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02939131 · ClinicalTrials.gov registry record · NA
IMPAACT 2002: Cognitive Behavioral Therapy and Medication Management for Treatment of Depression in US Youth With HIV
A NA study, sponsored by International Maternal Pediatric Adolescent AIDS Clinical Trials Group.
- Completed
- Registry status
- NA
- Development phase
- 156
- Enrollment target
NCT02939131 is a NA study that has completed, run by International Maternal Pediatric Adolescent AIDS Clinical Trials Group. The registered enrollment target is 156 participants.
The verdict
NCT02939131, a NA study, has completed, sponsored by International Maternal Pediatric Adolescent AIDS Clinical Trials Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 156 participants
- Enrollment target
Study Summary
IMPAACT 2002 is a prospective, multi-site, two-arm, cluster-randomized study to evaluate whether a health and wellness Cognitive Behavioral Therapy and Medication Management (COMB-R) intervention for depression demonstrates improved depression and medical outcomes for HIV-infected youth in the United States (US) compared to enhanced standard care (ESC).
Interventions
- BEHAVIORAL Enhanced Standard of Care
- BEHAVIORAL Health and Wellness Combined Cognitive Behavioral Therapy and a Medication Management Algorithm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2017-03-06 |
| Est. Completion | 2020-01-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02939131
The ClinicalTrials.gov registry entry for NCT02939131 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is International Maternal Pediatric Adolescent AIDS Clinical Trials Group, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Enhanced Standard of Care is the first listed.
NCT02939131 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02939131 about?
NCT02939131 is a clinical study titled "IMPAACT 2002: Cognitive Behavioral Therapy and Medication Management for Treatment of Depression in US Youth With HIV". IMPAACT 2002 is a prospective, multi-site, two-arm, cluster-randomized study to evaluate whether a health and wellness Cognitive Behavioral Therapy and Medication Management (COMB-R) intervention for depression demonstrates improved depression and medical outcomes for HIV-infected youth in the Unite...
What is the current status of trial NCT02939131?
This trial is currently completed. It is a NA study. The enrollment target is 156 participants. The study started on 2017-03-06. Estimated completion is 2020-01-21.
What interventions are being tested in trial NCT02939131?
The interventions under investigation include: Enhanced Standard of Care (BEHAVIORAL), Health and Wellness Combined Cognitive Behavioral Therapy and a Medication Management Algorithm (BEHAVIORAL).
Who is sponsoring clinical trial NCT02939131?
This trial is sponsored by International Maternal Pediatric Adolescent AIDS Clinical Trials Group, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.